InvivoSciences was featured in the October 2015 issue of MedTech Dealmakers. The article is titled “Predicting Cardiotoxicity with Engineereed 3D Human Cardiac Tissue Models.” InvivoSciences harnesses human induced pluripotent stem cells to generate patient-specific disease models for drug and diagnostics development.
Recent Comments